The global Melanoma Therapeutics market has witnessed an unprecedented boost in market size, owing to a dynamically evolving nature of melanoma treatments over the past few years. The high demand of novel early stage and advanced melanoma therapies along with a booming patient base, has created an impending need for better therapies in the melanoma market. Although, a plethora of treatment options are available today, several immunotherapy’s and combination therapies are expected to enter the market. Large uptake of these novel treatments is expected due to their improved survival benefits and minimal side effects. Additionally, untapped patient population, especially, in the Europe and U.S. would lead to a higher uptake of novel treatments in the near future.
Get Free Sample Report Of Melanoma Therapeutics Market @ http://www.marketresearchstore.com/report/world-melanoma-therapeutics-market-opportunities-and-forecasts-71678#RequestSample
According to the skin cancer foundation, an estimated total of 73,870 new diagnosed cases of melanoma are expected in 2015. With an expected death toll of 9,940 cases, melanoma would account for the majority of skin cancer deaths in 2015.
A strong emerging pipeline, rising incidences of melanoma cases and the increasing public awareness are the major factors driving the melanoma market. In addition, the growing interest of physicians towards novel therapies would fuel the market. Conversely, high costs incurred due to combination treatments and limited reimbursement is likely to curtail the market growth.
For companies like Bristol Myers Squibb (BMS), apposite product positioning of novel treatments in order to avoid cannibalization of marketed products would be a key challenge to sustain in the melanoma market.
Do Inquiry To Buy Report Of Melanoma Therapeutics Market @ http://www.marketresearchstore.com/report/world-melanoma-therapeutics-market-opportunities-and-forecasts-71678#InquiryForBuying
The Global Melanoma Therapeutics market segmentation is illustrated below:
Melanoma Therapeutics Market By Therapy Type
- Biologic therapy
- Targeted therapy
- Radiation therapy
- Other novel therapies (Virus based, Adjuvant therapy etc.)
Melanoma Therapeutics Market By Stages
- Stage 0 (Melanoma in Situ)
- Stage I
- Stage II
- Stage III
- Stage IV
Melanoma Therapeutics Market By Geography
- United States
- Rest of Europe
- Rest of Asia
- Latin America
- Middle East and Africa